Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer

NCT00005648 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

688

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Neoplasms

Interventions

DRUG: Gemcitabine with R115777
DRUG: Gemcitabine with Placebo

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.